# Insmed Incorporated clinical trials: 50 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 50 trials with Insmed Incorporated as lead sponsor, 7 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Insmed Incorporated: 50 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/insmed-incorporated

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 50
- Recruiting or not yet: 7
- Read on: November 19, 2026

## Trials

The 25 newest of 50, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 5, 2026 | NCT07859007 | A Study to Assess the Potential CYP3A Induction Effect of Brensocatib on the Pharmacokinetics (PK) of Midazolam in Healthy Participants | Insmed Incorporated | Phase 1 | Not yet recruiting | Healthy Volunteers | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859007) |
| September 4, 2026 | NCT07805785 | A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary... | Insmed Incorporated | Phase 3 | Recruiting | Progressive Pulmonary Fibrosis, Interstitial Lung Disease | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805785) |
| August 14, 2026 | NCT07765706 | A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants | Insmed Incorporated | Phase 1 | Recruiting | Healthy Volunteers | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765706) |
| June 11, 2026 | NCT07643155 | A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants... | Insmed Incorporated | Phase 1 | Recruiting | Hepatic Impairment | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07643155) |
| March 19, 2026 | NCT07481981 | A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Arterial Hypertension | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481981) |
| November 18, 2025 | NCT07234032 | An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07234032) |
| September 17, 2025 | NCT07179380 | Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07179380) |
| August 3, 2025 | NCT07102316 | A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP)... | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07102316) |
| April 23, 2025 | NCT06939647 | An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension... | Insmed Incorporated | Not applicable | Available | Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06939647) |
| November 13, 2024 | NCT06685835 | A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) | Insmed Incorporated | Phase 2 | Terminated | Hidradenitis Suppurativa | 214 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06685835) |
| April 3, 2024 | NCT06344728 | A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Participants | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06344728) |
| February 2, 2024 | NCT06238856 | Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology \[SLIT™\] Amikacin) in Participants With Cystic Fibrosis (CF)... | Insmed Incorporated | Phase 1 | Completed | Cystic Fibrosis | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06238856) |
| January 5, 2024 | NCT06193031 | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06193031) |
| December 21, 2023 | NCT06178783 | A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06178783) |
| October 26, 2023 | NCT06101823 | Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis) | Insmed Incorporated | Phase 2 | Completed | Atopic Dermatitis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06101823) |
| October 19, 2023 | NCT06091579 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06091579) |
| August 28, 2023 | NCT06013241 | A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) | Insmed Incorporated | Phase 2 | Completed | Chronic Rhinosinusitis Without Nasal Polyps | 288 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06013241) |
| August 21, 2023 | NCT05999942 | A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05999942) |
| July 28, 2023 | NCT05965570 | A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05965570) |
| July 3, 2023 | NCT05927597 | A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05927597) |
| April 24, 2023 | NCT05826574 | A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05826574) |
| January 6, 2023 | NCT05673603 | A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment | Insmed Incorporated | Phase 1 | Completed | Renal Impairment | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05673603) |
| December 15, 2022 | NCT05652257 | A Study of the Absorption, Metabolism, and Excretion of \[14C\]-Brensocatib Following a Single Oral Administration in Healthy Male... | Insmed Incorporated | Phase 1 | Completed | Healthy Volunteers | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05652257) |
| December 14, 2022 | NCT05649748 | An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH) | Insmed Incorporated | Phase 2/3 | Active not recruiting | Pulmonary Arterial Hypertension | 91 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05649748) |
| December 14, 2022 | NCT05649722 | An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease... | Insmed Incorporated | Phase 2/3 | Completed | Pulmonary Hypertension, Interstitial Lung Disease | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05649722) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 17 |
| Phase 1/2 | 3 |
| Phase 2 | 13 |
| Phase 2/3 | 3 |
| Phase 3 | 12 |
| Not applicable | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 36 |
| Recruiting | 6 |
| Terminated | 3 |
| Withdrawn | 1 |
| Available | 1 |
| Approved for marketing | 1 |
| Active not recruiting | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Cystic Fibrosis | 8 |
| Respiratory Tract Infections | 7 |
| Lung Diseases, Interstitial | 6 |
| Hypertension, Pulmonary | 5 |
| Pulmonary Arterial Hypertension | 5 |
| Mycobacterium Infections, Nontuberculous | 4 |
| Mycobacterium avium-intracellulare Infection | 2 |
| Pseudomonas Infections | 2 |
| Bronchiectasis | 2 |
| Laron Syndrome | 1 |
| Myotonic Dystrophy | 1 |
| Osteosarcoma | 1 |
| Recurrence | 1 |
| Neoplasm Metastasis | 1 |
| Renal Insufficiency | 1 |
| Dermatitis, Atopic | 1 |
| Eczema | 1 |
| Noonan Syndrome | 1 |
| Respiratory Tract Diseases | 1 |
| Lung Diseases | 1 |
| Hidradenitis Suppurativa | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Children's hospitals in the United States](https://specstream.ai/data/businesses/childrens-hospitals/united-states)
- [Restaurant wholesale companies in the United States](https://specstream.ai/data/businesses/restaurant-wholesale-companies/united-states)
- [Fingerprinting services in the United States](https://specstream.ai/data/businesses/fingerprinting-services/united-states)
- [Water purification companies in the United States](https://specstream.ai/data/businesses/water-purification-companies/united-states)
- [Law schools in the United States](https://specstream.ai/data/businesses/law-schools/united-states)
- [Bookkeeping firms in the United States](https://specstream.ai/data/businesses/bookkeeping-firms/united-states)
